Canada high court voids Pfizer's Viagra patent

Viagra pill

Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.

"Patent 2,163,446 is void," the Supreme Court said in its ruling.

The court explained that under Canadian patent rules an must "properly disclose the invention and how it works" in order to be granted "exclusive monopoly rights" for it.

It concluded that Pfizer knew and did not properly disclose that sildenafil is the only compound in Viagra, out of several listed compounds, that induces penile erection in impotent males.

"The is based on a 'bargain,' or quid pro quo: the inventor is granted exclusive rights in a new and useful invention for a limited period in exchange for disclosure of the invention so that society can benefit from this knowledge," the court said.

"If there is no proper disclosure, then there can be no exclusive monopoly rights."

Generic pharmaceutical company Teva brought the suit against Pfizer hoping to produce a generic version of Viagra before Pfizer's patent was due to expire in 2014.

The high court noted Pfizer had conducted tests proving sildenafil was the key to treating erectile dysfunction, and so concluded that "the invention was the use of sildenafil for the treatment of ED."

But 's patent only states that "one of the compounds (in Viagra) induces penile erection in impotent males, without specifying which is the effective compound."

Teva said in a statement it would soon start producing a of the drug that will be "priced significantly lower than Viagra," which will result in "millions in savings to consumers" and "make this medication accessible to people who might otherwise not have been able to afford it."

add to favorites email to friend print save as pdf

Related Stories

S. Korea to approve Viagra generics

Mar 14, 2012

Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

Thailand to sell generic Viagra drug: officials

Sep 26, 2012

Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.

Slovenia to launch generic version of Viagra

Jul 31, 2009

Krka, the biggest drugmaker in Slovenia, said Friday that its generic version of the impotency drug Viagra would be launched in September and priced 30 percent cheaper than the original.

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

Retailers sue Pfizer, charge generic Lipitor delay

Jul 07, 2012

(AP) — Five large U.S. drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

21 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments